Position in CSBR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$836,849
-$233,088 QoQ
Shares Held
145,539
-6.0% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. CSBR ranks #200 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in CSBR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $836,849 | 145,539 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,069,937 | 154,839 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,083,851 | 167,261 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,334,257 | 181,039 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,319,698 | 152,039 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,189,850 | 138,839 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $584,356 | 119,991 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $633,795 | 122,591 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $610,985 | 124,691 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $701,325 | 124,791 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $781,162 | 125,791 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $796,804 | 124,891 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $508,493 | 126,491 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $603,848 | 133,891 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,072,117 | 142,949 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,314,768 | 164,346 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,381,604 | 169,939 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,594,636 | 190,746 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,257,900 | 221,146 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,344,312 | 228,046 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,581,292 | 228,433 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,392,639 | 221,746 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,220,240 | 240,026 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,035,763 | 212,946 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,310,140 | 177,046 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||